Blood pressure variability: the challenge of variation.
Marshall
Tom P
TP
D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage*; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001562:Benzimidazoles / Q000008:administration & dosage*; D001713:Biphenyl Compounds; D001794:Blood Pressure / Q000187:drug effects*; D003198:Computer Simulation; D018849:Controlled Clinical Trials as Topic; D003951:Diagnostic Errors / Q000517:prevention & control; D004334:Drug Administration Schedule; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D015994:Incidence; D008955:Models, Cardiovascular; D009010:Monte Carlo Method; D017410:Practice Guidelines as Topic; D015203:Reproducibility of Results; D012107:Research Design; D013599:Systole; D013777:Tetrazoles / Q000008:administration & dosage*; D013997:Time Factors; D016896:Treatment Outcome
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; C081643:candesartan